Targeting adipokines: A new strategy for the treatment of myocardial fibrosis
Cardiac fibrosis is a pathogenic factor of many cardiovascular diseases (CVD), which seriously affects people's life and health, causing huge economic losses.Therefore, it is very significant to find an effective treatment for myocardial fibrosis. Adipokines are mainly derived from adipose tiss...
Main Authors: | Xiaoying Han, Yi Zhang, Xinyu Zhang, Haixia Ji, Wenzhe Wang, Ou Qiao, Xia Li, Juan Wang, Changxiao Liu, Luqi Huang, Wenyuan Gao |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-07-01
|
Series: | Pharmacological Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S104366182200202X |
Similar Items
-
Targeting Myocardial Fibrosis—A Magic Pill in Cardiovascular Medicine?
by: Alina Scridon, et al.
Published: (2022-07-01) -
Adipokines and Inflammation: Focus on Cardiovascular Diseases
by: Sandra Feijóo-Bandín, et al.
Published: (2020-10-01) -
The relationship of epicardial obesity and levels of cardiac fibrosis markers
by: O. V. Gritsenko, et al.
Published: (2019-05-01) -
Adipokines and Arterial Stiffness in Obesity
by: Ioana Para, et al.
Published: (2021-06-01) -
Effect of angiotensin-converting enzyme inhibitor on cardiac fibrosis and oxidative stress status in lipopolysaccharide-induced inflammation model in rats
by: Azam Abareshi, et al.
Published: (2017-01-01)